|
SEC61A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.830800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.139400E-01 |
| Normal-vs-Stage2 |
6.800600E-01 |
| Normal-vs-Stage3 |
6.061000E-01 |
| Normal-vs-Stage4 |
1.686430E-01 |
| Stage1-vs-Stage2 |
9.668600E-01 |
| Stage1-vs-Stage3 |
1.913610E-01 |
| Stage1-vs-Stage4 |
4.756400E-02 |
| Stage2-vs-Stage3 |
3.672200E-01 |
| Stage2-vs-Stage4 |
1.045430E-01 |
| Stage3-vs-Stage4 |
3.032400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.608600E-01 |
| Normal-vs-AfricanAmerican |
5.892800E-01 |
| Normal-vs-Asian |
1.180320E-02 |
| Caucasian-vs-AfricanAmerican |
4.999400E-01 |
| Caucasian-vs-Asian |
1.505750E-02 |
| AfricanAmerican-vs-Asian |
4.228000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.142000E-01 |
| Normal-vs-Female |
1.223790E-01 |
| Male-vs-Female |
1.416790E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.051200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.570600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.896400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.531000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.985800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.092200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.099400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.043400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.480800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.575800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.404600E-01 |
| Normal-vs-Grade 2 |
9.275400E-01 |
| Normal-vs-Grade 3 |
9.705200E-01 |
| Normal-vs-Grade 4 |
2.930400E-01 |
| Grade 1-vs-Grade 2 |
4.325000E-01 |
| Grade 1-vs-Grade 3 |
4.343200E-01 |
| Grade 1-vs-Grade 4 |
9.949200E-01 |
| Grade 2-vs-Grade 3 |
9.387600E-01 |
| Grade 2-vs-Grade 4 |
2.120800E-01 |
| Grade 3-vs-Grade 4 |
2.293600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.211000E-01 |
| Normal-vs-ccB subtype |
7.908600E-01 |
| ccA subtype-vs-ccB subtype |
5.203600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.590000E-01 |
| Normal-vs-N1 |
1.942610E-01 |
| N0-vs-N1 |
4.268400E-01 |
|
|
